Amyloid-Like Aggregates of the Yeast Prion Protein Ure2 Enter Vertebrate Cells by Specific Endocytotic Pathways and Induce Apoptosis by Zhang, Chen et al.
Amyloid-Like Aggregates of the Yeast Prion Protein Ure2
Enter Vertebrate Cells by Specific Endocytotic Pathways
and Induce Apoptosis
Chen Zhang








1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China, 2Department of Biochemistry, University of Cambridge,
Cambridge, United Kingdom, 3Department of Neurobiology and the Sino-Japan Joint Laboratory of Neurodegenerative Diseases, Beijing Institute of Geriatrics, Xuanwu
Hospital of the Capital University of Medical Sciences, Beijing, China, 4State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of
Sciences, Beijing, China, 5Graduate University of the Chinese Academy of Sciences, Beijing, China
Abstract
Background: A number of amyloid diseases involve deposition of extracellular protein aggregates, which are implicated in
mechanisms of cell damage and death. However, the mechanisms involved remain poorly understood.
Methodology/Principal Findings: Here we use the yeast prion protein Ure2 as a generic model to investigate how amyloid-
like protein aggregates can enter mammalian cells and convey cytotoxicity. The effect of three different states of Ure2
protein (native dimer, protofibrils and mature fibrils) was tested on four mammalian cell lines (SH-SY5Y, MES23.5, HEK-293
and HeLa) when added extracellularly to the medium. Immunofluorescence using a polyclonal antibody against Ure2
showed that all three protein states could enter the four cell lines. In each case, protofibrils significantly inhibited the
growth of the cells in a dose-dependent manner, fibrils showed less toxicity than protofibrils, while the native state had no
effect on cell growth. This suggests that the structural differences between the three protein states lead to their different
effects upon cells. Protofibrils of Ure2 increased membrane conductivity, altered calcium homeostasis, and ultimately
induced apoptosis. The use of standard inhibitors suggested uptake into mammalian cells might occur via receptor-
mediated endocytosis. In order to investigate this further, we used the chicken DT40 B cell line DKOR, which allows
conditional expression of clathrin. Uptake into the DKOR cell-line was reduced when clathrin expression was repressed
suggesting similarities between the mechanism of PrP uptake and the mechanism observed here for Ure2.
Conclusions/Significance: The results provide insight into the mechanisms by which amyloid aggregates may cause
pathological effects in prion and amyloid diseases.
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Introduction
Amyloid diseases are characterized by misfolding and aggrega-
tion of normal soluble peptide into b-sheet-rich oligomeric
structures and amyloid fibrils in specific tissues [1]. Among
amyloid diseases, prion diseases are unique in that the pathology
can be transmitted by an infectious process involving misfolding of
the prion protein to form an infectious state [2,3]. Prions are
infectious proteins that can transmit biological information by
propagating protein misfolding and aggregation. However, the
underlying pathological mechanism remains poorly understood.
Proteins that are not associated with disease can in some cases
be induced under extreme conditions to transform into amyloid-
like aggregates; the cytotoxic properties of the amyloid-like
aggregates formed from non-disease-related proteins [4] are
closely similar to those of disease-associated proteins such as the
Ab peptides, a-synuclein, and transthyretin [5–9]. This then
suggests that the cytotoxic properties may be determined by
common structural features of certain types of aggregates, rather
than by specific amino acid sequences. Increasing evidence
suggests that protofibrils, which are intermediates in the amyloid
fibril formation process, rather than mature fibrils, constitute the
toxic species [10,11].
Common histological findings include formation of aberrantly
folded proteins into extracellular plaques or intracellular inclusions
[12]. A deeper understanding of the detailed mechanism of protein
aggregation and the resulting cellular toxicity should lead to
rational drug design for this type of disease. Protein aggregates, in
the form of amyloid plaques, neurofibrillary tangles, and/or
intracytoplasmic or intranuclear inclusions, are thought to lead to
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12529damage of the cell membrane and disruption of ion homeostasis,
induction of apoptosis, and finally, cell death [13].
Ure2 is the protein determinant of the epigenetic factor [URE3]
of Saccharomyces cerevisiae, which has been demonstrated to represent
a prion of yeast [14,15]. Analogous to the mammalian prion
protein [2], Ure2 is aggregated and protease-resistant in prion
strains [14,15]. However, unlike mammalian prions, which exhibit
cytotoxicity in their aggregated form, Ure2 aggregates do not show
any marked toxic effect towards yeast cells. Ure2 forms amyloid-
like filaments in vitro, which share several morphological,
structural, and tinctorial features with amyloids, including
enhanced resistance to proteolysis, increased Thioflavin T (ThT)
fluorescence, and yellow-green birefringence in cross-polarized
light upon Congo red binding [16–19]. However, an unusual
property of Ure2 fibrils is their ability to maintain native-like
structure and activity within the fibrillar arrays [20–22].
Ure2 is a 354-amino acid cytoplasmic homodimeric protein
consisting of a relatively flexible and protease-sensitive N-terminal
region (,90 amino acids), and a globular C-terminal region
[17,23–25]. The N-terminal region is required for its prion
properties in vivo [15] and to form amyloid-like filaments in vitro
[16,26,27]. The C-terminal region shows structural similarity to
glutathione transferases (GSTs) [24,25,28], has glutathione-
dependent peroxidase activity [20], glutaredoxin activity [22],
and is necessary for the regulatory function of Ure2 in vivo: Ure2
interacts with the transcription factor Gln3 allowing control of
nitrogen catabolite repression, blocking the uptake of poor
nitrogen sources in the presence of a good nitrogen source [29,30].
The easy availability of different conformational states of Ure2
makes it an ideal model to investigate molecular features of the
toxicity of protein assemblies. Pieri and colleagues [31,32]
previously examined the effect of Ure2 aggregates on murine H-
END cells and found that different states of Ure2 aggregates were
toxic regardless of their aggregation state, which differs from what
has been proposed for amyloids, where toxicity follows extensive
molecular rearrangements and is usually restricted to protofibrillar
aggregates.
Here we investigated further the effect of Ure2 aggregates
towards a variety of mammalian cells lines, and the mechanism of
cytoxicity, in order to differentiate cell-specific effects from the
generic properties of particular types of amyloid-like aggregates. In
addition, we investigated the uptake pathway using a chicken
DT40 B cell line (DKOR), which allows conditional expression of
clathrin [33]. The results may shed light on the pathologic
mechanism and potential treatment strategies for prion and
amyloid diseases.
Results
Protofibrils of Ure2 significantly inhibited the growth of
four cell lines in a dose-dependent manner
The sigmoidal time course of formation of amyloid-like fibrils of
Ure2 is conveniently monitored using the fluorescent dye
Thioflavin T (ThT) [18]. Combining ThT binding fluorescence
and imaging by atomic force microscopy (AFM), different fibril
types of Ure2 (defined by morphology and/or thickness) are
observed to appear in a time dependent manner [27]. In this
study, fibrils were grown under conditions where fibril growth is
relatively slow (incubation at 4uC without agitation) and so
appearance of different fibril types is well separated in time
(Fig. 1A). Protofibrils were defined as small fibrillar aggregates
appearing early during the time course i.e. during the exponential
growth phase of the fibril growth curve (Fig. 1A) and having
thickness (i.e. height) of 3–10 nm, as measured by AFM (Fig. 1C).
Mature fibrils were defined as the longer, thicker fibrils that are
abundant in the final plateau phase of fibril grown (Fig. 1A), with a
height of 12–15 nm measured by AFM (Fig. 1D). Far-UV circular
dichroism (CD) spectra indicated that in contrast to native Ure2,
which shows a typical CD spectrum for an a–helical protein, the
protofibrils show a clear decrease in the relative a–helical content
(Fig. 1B).
We chose four cell lines: human SH-SY5Y neuroblastoma cells,
rat MES 23.5 dopaminergic neural cells, human HEK-293
embryonic kidney cells and human HeLa adenocarcinoma cells.
We then tested the effect of native Ure2 protein, protofibrils and
mature fibrils on the viability of the four cell lines, when added to
the extracellular medium. MTT assay results showed that addition
of protofibrils decreased the viability of all four cell lines in a dose
dependent manner (Fig. 2A). An equivalent concentration of
mature fibrils had less effect on cell viability than protofibrils in
HEK-293 and MES 23.5 cells, and mature fibrils showed no
cytotoxic effect in SH-SY5Y and HeLa cells (Fig. 2A). As a
control, native Ure2 had no effect on any of the cell lines (Fig. 2A).
The decrease in cell viability (Fig. 2A) was found to correlate with
a decrease in cell number (Fig. 2B). As a control, no obvious
morphological change was observed after incubating mature fibrils
or protofibrils under the conditions of the cell culture experiments
for 5 days (Fig. 3), indicating that the different fibrillar forms are
stable under the conditions of the cell culture experiments. The
observation of dose-dependent inhibition of growth of mammalian
cells after addition of Ure2 protofibrils, with a significantly lower
toxic effect of mature fibrils, agrees with the finding in murine H-
END cells [31]. However, a surprising finding in the previous
study was that native Ure2 was found to be toxic towards murine
H-END cells [31]. The above results suggest that although
different cell types showed different sensitivity towards mature
fibrils of Ure2, protofibrils of Ure2 consistently induce significant
inhibition of mammalian cell growth, in agreement with previous
results for a wide variety of disease-related and non-disease related
proteins [4–9]. These results support a model whereby particular
structural characteristics of aggregates formed early in the course
of amyloid formation convey toxic properties towards the cells
[10,11].
Native, protofibrillar, and fibrillar Ure2 can enter
mammalian cells
Immunofluorescence was carried out to investigate whether the
different states of Ure2 could enter into the four mammalian cell
lines. Potentially, the localization of the aggregates could shed light
on the toxic mechanism, by identifying the organelle where Ure2
conveys its effect. The results demonstrate that the different states
of Ure2 could each enter into the four cell lines but to different
extents (Fig. 4), with native Ure2 only present diffusely in the
cytoplasm, while protofibrils entered into the nucleus and
cytoplasm in SH-SY5Y, HeLa and MES 23.5 cells, with
observation of immnofluorescent-positive particles in SH-SY5Y
and MES 23.5 cells. Particles were also observed in the cytoplasm
of SH-SY5Y and MES 23.5 cells in the fibril treated group (Fig. 4).
Involvement of endocytotic pathways in uptake of Ure2
into mammalian cells
Having established that Ure2 could enter cells, in order to
investigate the mechanism of uptake of Ure2 further, we used four
different inhibitors that are considered to interfere with endocy-
totic pathways: nystatin (which disrupts lipid raft-mediated
endocytotic pathways), filipin (an inhibitor of caveolae-mediated
endocytosis), cytochalasin D (an inhibitor of macropinocytosis) and
Ure2 Aggregates Enter Cells
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assay the involvement of endocytotic pathways in the uptake of
Ure2 into cells. The results showed that nystatin and filipin could
inhibit the uptake of the aggregates into cells (Fig. 5B and C).
However, cytochalasin D and nocodazole did not affect uptake
(Fig. 5D and E). While use of such inhibitors gives only a crude
indication, this nevertheless suggests that Ure2 aggregates may
enter cells via specific endocytotic pathways, including lipid raft-
mediated and/or caveolae-mediated pathways.
Role of clathrin in endocytosis of Ure2 aggregates
In order to investigate the uptake pathway of Ure2 aggregates in
more detail, we used the DKOR cell line. The DKOR cell line
was derived by inactivation of both endogenous alleles of chicken
clathrin heavy chain in the DT40 B cell line followed by
introduction of human clathrin cDNA under the control of a
tetracycline-regulatable expression system (Tet-Off) [33]. Thus
using the DKOR cell line, it is possible to assess the role of clathrin
in the uptake of specific molecules. Immunofluorescence results
using Ure2 polyclonal antibody showed that native Ure2,
protofibrils and mature fibrils could all enter into DKOR cells
when clathrin was expressed (Fig. 6A). However, in DKOR cells
without expression of clathrin, a significant decrease in the extent
of uptake of the three states was apparent (Fig. 6B). When the
effect of different states of Ure2 on cell growth was examined,
protofibrils were found to show the most marked inhibition on
growth of DKOR cells, and this was most apparent when clathrin
was expressed (Fig. 6C and D).
In order to quantify the extent of uptake, we made use of the
enzymatic activity of the Ure2 protein, which is maintained in its
fibrillar state [20,22]. Using the glutaredoxin activity of Ure2 to
determine the extent of uptake, we observed that uptake of all
three states of the Ure2 protein was significantly reduced in the
absence of clathrin (Fig. 7). More striking though, was that the
amount of protein entering cells (and detectable after cell lysis and
assay of enzymatic activity) was significantly greater for protofibrils
than for either mature fibrils or native Ure2; this observation was
the same in the presence or absence of clathrin expression.
Protofibrils increased membrane conductivity in a
concentration dependent manner
Interaction between amyloid aggregates and the cell membrane
has been postulated to play an important role in the neuropa-
thology of Alzheimer’s, Parkinson’s and prion diseases [34]. We
used patch clamp to investigate the effect on the cell membrane of
mammalian cells induced by different states of Ure2. The I-V
curve showed that protofibrils increased membrane conductivity of
SH-SY5Y cells, whereas native Ure2 and fibrils had no effect
(Fig. 8A). Further, the effect of protofibrils was concentration-
dependent (Fig. 8B).
Protofibrils of Ure2 cause an increase in intracellular free
Ca
2+
Alteration of intracellular ion homeostasis is one of the earliest
and most common biochemical changes observed in cells exposed
Figure 1. Formation of amyloid-like structure for Ure2. Fibril formation was monitored by binding of the fluorescent dye ThT, AFM and CD. (A)
Kinetics of formation of amyloid-like structure for Ure2 monitored by ThT binding. (B) Far-UV CD spectra of 20 mM native Ure2 and protofibrils in
50 mM Tris-HCl buffer containing 0.2 M NaCl (pH 7.5). 20 mM Native Ure2 (2), 20 mM protofibrils of Ure2 (…). (C), (D) Morphology of amyloid-like
structures monitored by AFM for WT Ure2. (C) Protofibrils (height 3–10 nm) were abundant at early exponential growth phase of the fibril growth
curve. (D) Mature fibrils (height 12–15 nm) were predominant at later time points (plateau phase).
doi:10.1371/journal.pone.0012529.g001
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PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12529Figure 2. Effects of Ure2 aggregates on the cell viability and proliferation of four cultured cell lines. The cell lines were SH-SY5Y, HEK-
293, HeLa and MES 23.5. *P,0.01 compared with the control group. The results shown are the mean of at least three independent measurements
and the error bars represent the S.E. of the mean. (A) MTT assay of cell viability after incubation for 48 h with different aggregated states of Ure2
protein. The concentration of Ure2 species shown in the x-axis of the figure was determined as described in the Materials and Methods. (B) Growth
curves of the cell lines in the presence of Ure2 aggregates. The concentrations of Ure2 species were 3 mM.
doi:10.1371/journal.pone.0012529.g002
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intracellular free Ca
2+, we added protofibrils, fibrils or native Ure2
extracellularly to Fluo-3-loaded SH-SY5Y cells. The result showed
that protofibrils caused an increase in the intracellular Ca
2+ from
about 30 min after addition, reaching a maximal level at around
2 h, after which the Ca
2+ level decreased again (Fig. 9). Mature
fibrils of Ure2 also caused an increase in intracellular Ca
2+, with a
similar time profile to protofibrils, but the effect was not as large,
while native Ure2 evoked no significant change (Fig. 9).
Protofibrils of Ure2 induced cell apoptosis
Apoptosis and necrosis of cells may both be triggered by
amyloid aggregate toxicity [36–38]. We therefore investigated
whether the changes in membrane conductivity and free Ca
2+
levels induced by Ure2 aggregates lead to cell death, and if so,
whether activation of apoptosis was involved. We measured the
activity of caspase-3, an important element in signaling
transduction leading to apoptosis [39]. After incubation with
protofibrils, the caspase 3 activity of SH-SY5Y cells was found to
increase 5-fold compared with the control group (Fig. 10A). This
is consistent with the effect seen in murine H-END cells [31].
Early apoptotic cells are characterized by exposure of phospho-
lipid normally found in the inner membrane, whereas necrotic
cells undergo membrane rupture. We used annexin V and
propidium iodide (PI) double labeling to detect phosphatidylser-
ine externalization and membrane integrity in our cell model.
Under these conditions, protofibril-treated cells displayed high
annexin V and low PI binding, indicating apoptosis rather than
necrosis (Fig. 10B). These results indicate that protofibrils of Ure2
cause cell death by triggering the apoptotic pathway, rather than
by causing necrosis.
Discussion
The S. cerevisiae prion protein Ure2 forms amyloid-like filaments
in vitro, which share similar morphological, structural, and
tinctorial features with amyloids [16]. In this study, we used
Ure2 as a generic model to investigate aspects of the underlying
mechanisms of amyloid and prion diseases. A particular advantage
of using an exogenous protein such as Ure2 in this type of study, is
that the lack of Ure2 present in the original cell-lines means that its
uptake can be clearly and unambiguously followed. Another
advantage of Ure2 is that the time course of fibril formation is well
studied and relatively easily controlled, allowing separation of
different types of aggregates for comparative study [27]. In this
study, protofibrils were defined as aggregates with diameter 3–
10 nm (Fig. 1), similar to those observed for many different types
of amyloids by electron and atomic force microscopy [40–42].
Mature fibrils were abundant in the final plateau phase of fibril
growth and had a height of 12–15 nm (Fig. 1). This pattern of
distribution of fibril morphologies has been observed for many
amyloidogenic proteins, including islet amyloid [41], a-synuclein
[42] and non-disease associated ‘‘neoamyloids’’ [4].
Figure 3. Comparison of the morphology of Ure2 aggregates before and after incubation under the conditions of the cell culture
experiments. Electron microscopy images of negative-stained Ure2 fibrils and protofibrils are shown. Scale bars =200 nm. (A) Freshly prepared
mature fibrils of Ure2. (B) Mature fibrils of Ure2 after incubation in DMEM for 5 days. (C) Freshly prepared protofibrils of Ure2. (D) Protofibrils of Ure2
after incubation in DMEM for 5 days.
doi:10.1371/journal.pone.0012529.g003
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mammalian cells, and to be able to differentiate between general
toxic effects of amyloid aggregates, versus effects that might be cell
specific, we chose four different cell lines: SH-SY5Y, MES23.5,
HEK-293 and HeLa (see Materials section for further details). The
results show that the different aggregation states of the Ure2
protein conveyed different effects on mammalian cells: protofibrils
significantly inhibited the growth of the cells in a dose-dependent
manner, mature fibrils showed less toxicity than protofibrils, while
the native state had no effect on cell growth. This suggests that
cytotoxicity reflects specific structural characteristics that are
present in the protofibril state, consistent with the conclusions
drawn from studies using a wide variety of disease-related and
non-disease related proteins [4–9,43]. The finding here that native
Ure2 is benign towards a range of mammalian cell types, unlike
the previously reported effects on murine H-END cells [31],
suggests that murine H-END cells may have unique characteristics
in their response to the heterologous protein Ure2, that are not
representative of neuronal and other cell types. The observation of
different susceptibility among different cell lines to the cytotoxic
effects of the aggregates may be related to variations in the glycerol
phospholipid content of the cell membrane [44], cell differentia-
tion [45], or other cell-specific factors. The lower levels of
cholesterol in the membrane of H-END cells may be related to its
high susceptibility to Ure2 aggregates. Similarly, the higher level of
cholesterol in the membrane of HeLa cells may explain their
reduced susceptibility to the toxic effects of Ure2 aggregates
compared to the other cell lines examined in this study.
In order to determine whether the cytotoxic effects of Ure2
aggregates were exerted from inside or outside the cells, we
followed the fate of the Ure2 protein by immunofluorescence
labeling using an antibody that recognizes both native and
fibrillar states of Ure2. The results demonstrate that the three
different states of Ure2 entered into the four cell lines to different
extents (Fig. 4). In general, the accumulation of protofibrils and
fibrils within the cells was more apparent than for native Ure2. In
the previous study using murine H-END cells, mature fibrils
could not enter into cells but only adsorbed on to the plasma
membrane, while protofibrils and native dimer were observed
both intracellularly and on the membrane [31]. Clearly,
Figure 4. Immunofluorescence labeling of Ure2 after extracellular addition to the cell lines. Labeling with Ure2 polyclonal antibody was
carried out in the SH-SY5Y, HEK-293, HeLa and MES 23.5 cell lines 48 h after extracellular addition of different states of Ure2 protein (bar=12 mm). The
concentration of Ure2 and its fibrillar species used here was 3 mM. The images shown are cell sections obtained by confocal microscopy, as described
in the Materials and Methods.
doi:10.1371/journal.pone.0012529.g004
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whereas the uptake of mature fibrils seems to be more susceptible
to cell-specific factors.
The mechanism of uptake into cells is of particular interest, as
internalization of PrP is thought to be involved in the mechanism
of prion disease [46,47] and this also has implications for the
mechanism of damage caused by extra-cellular amyloid deposits in
diseases such as Alzheimer’s [48]. We found that regardless of the
aggregation state, Ure2 could enter mammalian cells via specific
endocytotic pathways, with both lipid-raft and caveolae-mediated
pathways being implicated (Fig. 5). Further, the presence of
clathrin was found to assist uptake into vertebrate cells (Fig. 6).
Clathrin-coated vesicles play a fundamental role in eukaryotic
cells. They internalize selected cell-surface molecules by receptor-
mediated endocytosis [49]. The clathrin-dependent endocytotic
pathway is the best characterised specific endocytotic pathway
[50]. Both the immunofluorescence results, and quantification of
the amount of Ure2 taken up into cells using its intrinsic enzymatic
activity, indicate that the presence of clathrin increases the amount
of Ure2 taken up into DKOR cells, particularly for protofibrils.
Further, the increased cytoxicity of protofibrils correlates with the
increased amount of protofibrils detected within cells. This
suggests that protofibrils are endocytosed more efficiently than
other aggregate types and/or that they are less prone to
degradation during the process of incubation, uptake and
accumulation within the cells. This is consistent with the finding
that fibril length correlates with the ability to disrupt membranes
and to reduce cell viability for a number of amyloidogenic proteins
[51]. Interestingly, these results suggest that the uptake mechanism
of Ure2 may resemble the internalization mechanism of the
mammalian prion protein, PrP, where lipid-raft, calvaeolae and
clathrin-mediated mechanisms have all been implicated [52,53].
These three pathways are not mutually exclusive and may
cooperate to uptake the same antigen under different conditions.
Here we observe reduced uptake of Ure2 aggregates in the
absence of clathrin. This is similar to B cell receptor uptake, which
was in addition found to utilize both raft and actin-dependent non-
clathrin pathways [54].
In order to understand the mechanism by which the aggregates
induce cell damage and death, we examined the effects of
aggregates on the cell membrane, and also looked for signs of
apoptosis. We found that protofibrils of Ure2 cause cell death by
triggering the apoptotic pathway, rather than by causing necrosis,
which agrees with observations with Ure2 in murine H-END cells
[31] and other aggregates in other cell types [35–37]. A growing
body of evidence suggests that an increase in membrane
permeability induced by amyloid protofibrils may represent a
common, primary mechanism of pathogenesis in amyloid-related
degenerative diseases [13]. We therefore used patch clamp, which
is the classic method to detect changes in the permeability of the
cell membrane. Our results indicate that only protofibrils induced
an increase in membrane conductivity, with no detectable change
in the case of the native dimer or mature fibrils of Ure2 (Fig. 8). In
electron microscopy experiments with immuno-labelling of Ure2
aggregates (data not shown), formation of pores within the
membrane could not be detected, whereas this has been reported
for Ab, a-synuclein, IAPP, polyglutamine, and PrP [55–61].
However, our results are in general agreement with the suggestion
that amyloids permeabilize membranes and that the specific
structural properties of protofibrils contribute to the efficiency of
this activity. Changes in the membrane could in turn induce
intracellular signal transduction pathways, leading to the apoptosis
response that was detected in protofibril-treated cells (Fig. 10).
These early changes at the membrane may initiate a series of
downstream pathological events that represent a common
pathway for degeneration in amyloid-related diseases. Indeed,
consistent with the cytotoxicity and apoptosis results, extracellular
addition of protofibrils caused a significant increase in cytosolic
free Ca
2+, whereas equivalent amounts of native dimer had no
detectable effect (Fig. 9). The increase in intracellular Ca
2+ levels
may result from an increase in membrane permeability, but it
could also result as a consequence of altered intracellular signaling,
Figure 5. Inhibition of endocytotic uptake of Ure2 protofibrils. 3 mM Ure2 protofibrils and nystatin, filipin, nocodazole or cytochalasin D was
added extracellularly to MES 23.5 cells. After 48 h incubation, the cells were subjected to immunofluorescence assay (bar=25 mm). (A) Control (no
inhibitor). (B) 100 mg/ml nystatin. (C)5mg/ml filipin. (D)5 0mg/ml cytochalasin D. (E)5 0mmol/l nocodazole.
doi:10.1371/journal.pone.0012529.g005
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2+ increase itself could induce many signaling
transduction pathways.
Elucidation of the uptake mechanism of amyloid aggregates and
which pathways are involved in the toxic mechanism has
significant implications for therapeutic development. Targeting
downstream pathways may not be effective if there are multiple,
parallel pathways. If cytotoxic effects are predominantly mediated
from within the cell, then blocking the uptake of extracellular
aggregates (or aggregation-prone proteins) into cells might be an
effective way to prevent cytotoxicity. In this case, focusing on the
uptake mechanism would also be an effective strategy, even if
multiple downstream pathways are involved. Recent evidence
suggests that the mechanism and machinery for prion propagation
may be conserved between yeast and higher eukaryotes [62,63],
and the primary mechanism of pathogenesis in prion and amyloid
diseases may have important common features, providing hope for
development of broadly applicable therapeutics that will be
effective against these devastating diseases. This study suggests
Figure 6. Effects of Ure2 aggregates on the DKOR cell line. (A), (B) Immunofluorescence co-labeling for clathrin and Ure2 in the DKOR cell line
at 48 h after extracellular addition of 3 mM different states of Ure2. Green fluorescence is clathrin, red is Ure2 and blue is Hoechst 33258 nuclear stain
(bar=12 mm). (A) DKOR cells with expression of clathrin. (B) DKOR cells without expression of clathrin. (C), (D) Growth curves of the DKOR cell line in
the presence of 3 mM Ure2 or its amyloid aggregates. The error bars represent the S.E. of the mean of three independent measurements. (C) DKOR
cells with expression of clathrin. (D) DKOR cells without expression of clathrin.
doi:10.1371/journal.pone.0012529.g006
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ThT, Tris, nystatin, filipin, nocodazole, cytochalasin D, reduced
glutathione, glutathione reductase, NADPH, 1-chloro-2,4-dinitro-
benzene, penicillin, streptomycin, poly-L-lysine, tetracycline and
Fluo-3-acetoxymethyl ester were from Sigma. Human SH-SY5Y
neuroblastoma cells, human HEK-293 embryonic kidney cells
(which have certain neuronal properties [64]), MES 23.5 rat
dopaminergic neural cells and human HeLa adenocarcinoma cells
were from ATCC. Fetal bovine serum (FBS) and chicken serum
were from Hyclone. Dulbecco’s modified Eagle medium (DMEM)
and RPMI 1640 were from Gibco. All other reagents were local
products of analytical grade. Millipore water was used throughout.
Protein production
Ure2 was produced in Escherichia coli with a short His tag and
purified under native conditions as described previously [23], except
that aFrenchpresswasused in placeofsonicationtodisrupt thecells.
Protein was stored at 280uCand defrosted in a 25uCw a t e rb a t h
immediately prior to use. Samples were prepared in 50 mM Tris-
Figure 7. Quantification of the amount of Ure2 entering into
the DKOR cell line using enzymatic activity of Ure2. Cells were
assayed 48 h after extracellular addition of different states of Ure2. The
percentage on the y-axis represents the ratio of glutaredoxin activity of
Ure2 species within DKOR cells to the total activity of Ure2 species
added into the cell culture. Lysates of clathrin-expressing and clathrin-
depleted cells which were not incubated with Ure2 or aggregates were
assayed as controls. The glutaredoxin activity of Ure2 or its aggregates
in the cell lysates is shown after subtraction of the activity of the
control. The reaction conditions are described in the Materials and
Methods. The results shown are the mean of three independent
measurements and the error bars represent the S.E. of the mean.
*P,0.01 compared with protofibril group in DKOR cells with expression
of clathrin. **P,0.05 compared with DKOR cells without expression of
clathrin.
doi:10.1371/journal.pone.0012529.g007
Figure 8. Effect of Ure2 aggregates on membrane conductivity of SH-SY5Y cells. (A) Protofibrils induced increase of membrane
conductivity. Buffer, 1 mM native Ure2, 1 mM fibrils and 1 mM protofibrils of Ure2 were added sequentially. (B) Protofibrils increased the membrane
conductivity in a concentration dependent manner. Currents were recorded in response to voltage ramps from 2100 to +100 mV at a rate of 50 mV/
s. Curves are labeled with the concentration of Ure2 protofibrils used in the assay.
doi:10.1371/journal.pone.0012529.g008
Figure 9. Protofibrils induced a concentration change in
intracellular free Ca
2+ in SH-SY5Y cells. Analysis was performed
using Quantity One software (Bio-Rad). The maximum intensity of
fluorescence was defined as 100%. The results shown are the mean of
at least three independent measurements and the error bars represent
the S.E. of the mean.
doi:10.1371/journal.pone.0012529.g009
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at 30,000 g for 30 min at 4uC to remove any aggregated protein.
Amyloid formation
The kinetics of amyloid formation of Ure2 proteins was
monitored using ThT binding fluorescence as described previously
[19,27]. Incubation was at a constant temperature of 4uC without
shaking. Samples were incubated in parallel whenever possible.
When comparing the time course of amyloid formation by ThT
binding and AFM, samples were taken simultaneously from the
same reaction vessel whenever possible. The Ure2 aggregates were
also isolated for visualization by atomic force microscopy or
electron microscopy. Different Ure2 amyloid species (protofibrils
or mature fibrils) were isolated by centrifugation at 18,000 g for
30 min at 4uC. Then, the soluble Ure2 concentration in the
supernatant fraction was determined by absorbance at 280 nm as
described [23]. The concentration of Ure2 fibrillar species was
obtained by subtraction of the initial total soluble Ure2
concentration in the original sample and supernatant fraction
after formation of fibrillar species.
Atomic force microscopy
AFM was used to analyze the change in morphology of Ure2
aggregates over time and was carried out essentially as described
[27]. A 10 ml drop of the protein sample was deposited on freshly
cleaved mica, allowed to stand for 5 min in air, and then washed
with two 100 ml aliquots of distilled deionized water, before drying
for 5 min in a stream of nitrogen. Tapping mode AFM was
performed using a Nanoscope IIIa Multimode-AFM instrument
(Digital Instruments) under ambient conditions. Super-sharp silicon
tips (Silicon-MDT Ltd) with resonance frequency of about 106 kHz
were used at a scan rate of 1–2 Hz. Once the tip was engaged, the
set point value was adjusted to minimize the force exerted on the
sample while maintaining the sharpness of the image. Samples were
imaged at scan sizes between 1 mm and 10 mm using line scan rates
below 2 Hz and 5126512 pixels were collected per image.
Electron microscopy
5-ml aliquots of the fibril suspension were applied to carbon-
coated copper grids for 1 min. The grids were blotted, washed
twice in droplets of double distilled water, stained with 1% uranyl
acetate, and observed with a Phillips Tecnai 20 electron
microscope at 120 kV.
Circular dichroism
Spectra were recorded over the range 200–250 nm in a Pistar-
180 Spectrometer (Applied Photophysics, UK). Samples were
removed and centrifuged at 30,000 g for 30 min to remove large
aggregates. Spectra of 20 mM native and protofibrillar Ure2 were
measured at 25uC in a 0.1 mm path-length thermostatted cuvette.
Data were acquired with a step size of 1 nm. For each sample, the
mean residue ellipticity shown is the average of three scans.
Cell culture
SH-SY5Y, HEK-293 and HeLa cells were cultured in DMEM,
supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/
ml streptomycin. MES 23.5 cells were coated with poly-L-lysine
(10 mg/ml), and cultured in DMEM supplemented with 20% FBS,
100 U/ml penicillin and 100 mg/ml streptomycin. The cells were
incubated at 37uC in humidified 5% CO2. The DKOR cell line
was maintained in RPMI 1640 with 10% FBS, 1% chicken serum,
10 mM HEPES, and 50 mM 2-mercaptoethanol [33].
Assay of cellular toxicity
The cells were plated onto 96-well plates and incubated with
different states of Ure2 for 48 h. Aggregate cytotoxicity was
assessed using the MTT reduction inhibition assay [65]. The
absorbance of blue formazan was measured at 590 nm using an
automatic plate reader (Thermo). Control experiments were
performed by exposing cells to solutions of an equivalent volume
of the same buffer for the same length of time. Cell growth curves
were obtained by counting the number of cells. The cells were
plated onto 24-well plates and incubated with different states of
Ure2. The cell number per ml of medium was counted using a
hemacytometer and recorded every day until the eighth day.
Immunofluorescence
SH-SY5Y, HEK-293, HeLa and MES 23.5 cells were grown on
glass coverslips in 24-well plates. After 48 h incubation with
different states of Ure2, the cells were fixed with 4% paraformal-
Figure 10. Protofibrils of Ure2 induced apoptosis of SH-SY5Y cells. (A) Caspase-3 activity of SH-SY5Y cells increased 5 times with respect to
the control group after treatment with protofibrils. The error bars represents the S.E. of the mean of at least three independent measurements. (B)
Apoptosis assay of SH-SY5Y cells after treatment with protofibrils. Green represents annexin V staining, indicating apoptosis. Red represents
propidium iodide staining, indicating necrosis. The cells shown are representative for a total of 10 fields (more than 100 cells) that were imaged
(bar=12 mm).
doi:10.1371/journal.pone.0012529.g010
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Triton X-100. The cells were then incubated overnight at room
temperature with polyclonal anti-rabbit antibody against Ure2
(1:2000) followed by incubation at room temperature for 2 h with
FITC/anti-rabbit IgG (1:100) and then subjected to confocal
microscopy using a Nikon Microphot-FXA confocal laser scanning
microscope. Detection of clathrin in DKOR cells was performed
as described previously [54]. Images were processed using Adobe
Photoshop software.
Apoptosis assay
Caspase-3 activity was measured using a kit from Clontech.
After 24 h incubation with different states of Ure2, SH-SY5Y cells
were lysed with a buffer containing 10 mM Tris–HCl, pH 7.4,
10 mM NaCl, 1 mM PMSF, 1 mM EDTA and 0.01% (w/v)
SDS. Samples were then centrifuged at 12,000 g for 20 min and
the protein concentration was determined by the BCA method
(Pierce). Aliquots of cytosolic extracts (20 mg protein in 100 ml
caspase-3 assay buffer consisting of 50 mM Hepes, pH 7.4,
100 mM NaCl, 0.1% CHAPS, 10 mM DTT, 1 mM EDTA,
and 10% glycerol) were mixed with equal volumes of 40 mM
colorimetric tetrapeptide substrate (Ac-DEVD-pNA) in the same
buffer and monitored using an ELISA plate reader (Thermo). To
detect early sign of apoptosis, an annexin V and PI double-staining
kit was used (Keygen biotech). Cells were washed with phosphate-
buffered saline once and then stained with annexin V and 1 mg/ml
PI for 10 min at room temperature and then subjected to
fluorescence microscopy.
Endocytosis inhibition assay
MES 23.5 cells were grown on glass coverslips in 35 mm culture
dishes (Nunc). 3 mM Ure2 protofibrils and 100 mg/ml nystatin,
5 mg/ml filipin, 50 mmol/l nocodazole or 50 mg/ml cytochalasin
D were added extracellularly. After 48 h of incubation, the cells
were subjected to immunofluorescence assay as described above.
Patch clamp
Silver chloride wires were used as electrodes to apply voltages
and record currents across the cell membrane. The rear-chamber
potential was taken as ground, and the additions were made to the
front chamber. For measurements of membrane conductance a
ramp protocol (2100 to +100 mV, 50 mV/s) was used. Voltages
were generated and currents digitized at a resolution of 12 bits by
an AD Laboratory ADC/DAC board running software written in
the laboratory. Currents were transduced by an Axopatch 200 A
amplifier (Axon Instruments, Foster City, CA) connected to the
AD Laboratory board. Buffer, native Ure2, mature fibrils and
protofibrils were added sequentially to SH-SY5Y cells. Increasing
concentrations of protofibrils were added to record the I-V curve.
Intracellular free Ca
2+ concentration
Prior to Ure2 addition, SH-SY5Y cells were incubated at 37uC
for 5 min with 5.0 mM Fluo-3-acetoxymethyl ester which labels
free Ca
2+. The cells then were washed with serum-free DMEM
without phenol red to remove the excess probe and mounted on
the stage of the confocal microscope. Native Ure2, protofibrils or
mature fibrils of Ure2 were added to the cells, and Fluo-3
fluorescence was monitored at 488 nm 5 min after Ure2 addition
using the software Time Course Kinetic (Olympus). The same
field was imaged from 30 min to 4 h. Fluorescence quantification
was performed using Quantity One software (Bio-Rad).
Quantification of Ure2 uptake
Clathrin-expression in DKOR cells was inhibited by incubation
of the cells with 100 ng/ml doxycycline for 72 h prior to assay
[33]. Clathrin-expressing and clathrin-depleted cells were incu-
bated with different states of Ure2 for 48 h and then lysed as
described above (see Apoptosis assay). The quantity of different
states of Ure2 entering into cells was determined by assay of
glutaredoxin enzymatic activity, as described previously [22]. The
reaction conditions were 1.5 mM Ure2, 1.5 mM aggregates or
100 ml cell lysate, 100 mM sodium phosphate, pH 7.5, 1.5 mM
reduced glutathione, 3 mM 2-hydroxyethyl disulfide, 0.5 units/ml
glutathione reductase, 0.2 mM NADPH, and 1 mM EDTA at
25uC. Lysates of clathrin-expressing and clathrin-depleted cells
which were not incubated with Ure2 or aggregates were also
assayed as controls. The glutaredoxin activity of Ure2 or its
aggregates in the cell lysate was obtained by subtracting the
activity of the respective control.
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